BF Biosciences Limited (PSX:BFBIO)
138.54
-1.64 (-1.17%)
At close: Mar 11, 2026
-26.81% (1Y)
| Market Cap | 12.24B -29.3% |
| Revenue (ttm) | 8.22B +82.0% |
| Net Income | 598.64M +39.9% |
| EPS | 6.78 +8.5% |
| Shares Out | 88.33M |
| PE Ratio | 20.43 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 129,068 |
| Average Volume | 282,021 |
| Open | 140.20 |
| Previous Close | 140.18 |
| Day's Range | 138.00 - 141.00 |
| 52-Week Range | 117.00 - 194.90 |
| Beta | n/a |
| RSI | 39.72 |
| Earnings Date | Feb 25, 2026 |